Excerpt: “[The company] benefits from two themes: domestic medical devices replacing foreign brands, and demand growth for the aesthetic,” said Ke Yan, an IPO analyst at DZT Research publishing on the Smartkarma platform.
Nikkei Asian Review – Business • (Opens in a new window) ⧉
Are you a Professional Journalist?
The Smartkarma Press Pass is a special login created exclusively for pre-approved professional journalists. It allows a journalist to access content on the platform and use all the powerful search and discovery functionality available. Journalists can excerpt and quote from the content on Smartkarma to enrich and support their articles.
